Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Gut|March 8, 2013
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatmentCornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2022
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2Simon Woelfel, Joel Dütschler, Marius König, et al.
Life Science Alliance|December 12, 2019
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosisRobert Brenig, Oltin T Pop, Evangelos Triantafyllou, et al.
Vaccines|July 30, 2025
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Nature|April 11, 2014
Protective mucosal immunity mediated by epithelial CD1d and IL-10Torsten Olszak, Joana F Neves, C Marie Dowds, et al.
Aging Cell|March 24, 2016
Immunochip analysis identifies association of the RAD50/IL13 region with human longevityFriederike Flachsbart, David Ellinghaus, Liljana Gentschew, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Inflammatory Intestinal Diseases|August 15, 2024
Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Jeanine Wakim El-Khoury, Ekaterina Safroneeva, Catherine Saner, et al.
Vaccines|July 27, 2024
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel diseaseSimon Woelfel, Joel Dütschler, Marius König, et al.
Pageof 16